Van Cleef Asset Management »

ZIOPHARM Oncology shares owned by Van Cleef Asset Management

Quarter-by-quarter ownership of ZIOPHARM Oncology shares owned by Van Cleef Asset Management from 13F filings

Historical chart of Van Cleef Asset Management investment in ZIOPHARM Oncology

Tip: Access up to 7 years of quarterly data

All positions including ZIOPHARM Oncology held by Van Cleef Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ZIOPHARM Oncology by Van Cleef Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0k 14k 0.07
2023-09-30 $1.9k 14k 0.13

More positions owned by Van Cleef Asset Management

Progressive Corporation (PGR)
Apple (AAPL)
Vanguard Index Fds Extend Mkt Etf (VXF)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Lamar Advertising Cl A (LAMR)
Linde SHS (LIN)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Paychex (PAYX)
Exxon Mobil Corporation (XOM)
Mccormick & Co Com Non Vtg (MKC)
Stryker Corporation (SYK)
Alphabet Cap Stk Cl C (GOOG)
Palantir Technologies Cl A (PLTR)

View all positions for Van Cleef Asset Management

Top funds holding ZIOPHARM Oncology

MSDC Management
Vanguard Group
Discovery Capital Management
Advisor Group Holdings
Squarepoint Ops
Two Sigma Investments
Two Sigma Securities
Citadel Advisors
UBS Group
Atria Wealth Solutions
Charles Schwab Investment Management
Wells Fargo & Company
Franklin Resources
Millennium Management
William Blair $ Company

View all funds holding ZIOPHARM Oncology